Ameriprise Financial 10-Q 2022-03-31
Filed 2022-05-02. 7 sections, 397K characters. Original on sec.gov · Markdown · JSON
Cover and table of contents
| UNITED STATES | ||||||||||||||
| SECURITIES AND EXCHANGE COMMISSION | ||||||||||||||
| WASHINGTON, D.C. 20549 | ||||||||||||||
| FORM | 10-Q |
| ☒ | QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 | |||||||
| For the Quarterly Period Ended | March 31, 2022 | |||||||
| OR | ||||||||
| ☐ | TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 | |||||||
| For the Transition Period from_______________________to_______________________ |
| Commission File No. | 1-32525 |
| AMERIPRISE FINANCIAL, INC. | ||
| (Exact name of registrant as specified in its charter) |
| Delaware | 13-3180631 | |||||||||||||
| (State or other jurisdiction of incorporation or organization) | (I.R.S. Employer Identification No.) |
| 1099 Ameriprise Financial Center | Minneapolis | Minnesota | 55474 | |||||||||||||||||||||||
| (Address of principal executive offices) | (Zip Code) |
| Registrant’s telephone number, including area code: | (612) | 671-3131 |
| Former name, former address and former fiscal year, if changed since last report: | Not Applicable |
| Securities registered pursuant to Section 12(b) of the Act: | ||||||||||||||||||||
| Title of each class | Trading Symbol | Name of each exchange on which registered | ||||||||||||||||||
| Common Stock (par value $.01 per share) | AMP | New York Stock Exchange |
| Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. | Yes | ☒ | No | ☐ |
| Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). | Yes | ☒ | No | ☐ |
| Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act. | |||||||||||||||||
| Large Accelerated Filer | ☒ | Accelerated Filer | ☐ | Non-accelerated Filer | ☐ | ||||||||||||
| Smaller reporting company | ☐ | Emerging growth company | ☐ |
| If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. | ☐ |
| Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). | Yes | ☐ | No | ☒ |
| Indicate the number of shares outstanding of each of the issuer’s classes of common stock, as of the latest practicable date. | ||||||||||||||
| Class | Outstanding at April 22, 2022 | |||||||||||||
| Common Stock (par value $.01 per share) | 109,904,488 shares | |||||||||||||
AMERIPRISE FINANCIAL, INC.
FORM 10-Q
INDEX
AMERIPRISE FINANCIAL, INC.
PART I. FINANCIAL INFORMATION
Item 1. FINANCIAL STATEMENTS (UNAUDITED)
CONSOLIDATED STATEMENTS OF OPERATIONS (UNAUDITED)
| Three Months Ended March 31, | |||||||||||||||||||||||
| 2022 | 2021 | ||||||||||||||||||||||
| (in millions, except per share amounts) | |||||||||||||||||||||||
| Revenues | |||||||||||||||||||||||
| Management and financial advice fees | $ | 2,459 | $ | 2,102 | |||||||||||||||||||
| Distribution fees | 446 | 458 | |||||||||||||||||||||
| Net investment income | 261 | 377 | |||||||||||||||||||||
| Premiums, policy and contract charges | 368 | 347 | |||||||||||||||||||||
| Other revenues | 123 | 71 | |||||||||||||||||||||
| Total revenues | 3,657 | 3,355 | |||||||||||||||||||||
| Banking and deposit interest expense | 2 | 5 | |||||||||||||||||||||
| Total net revenues | 3,655 | 3,350 | |||||||||||||||||||||
| Expenses | |||||||||||||||||||||||
| Distribution expenses | 1,297 | 1,175 | |||||||||||||||||||||
| Interest credited to fixed accounts | 141 | 159 | |||||||||||||||||||||
| Benefits, claims, losses and settlement expenses | 211 | 653 | |||||||||||||||||||||
| Amortization of deferred acquisition costs | 96 | 5 | |||||||||||||||||||||
| Interest and debt expense | 40 | 42 | |||||||||||||||||||||
| General and administrative expense | 947 | 823 | |||||||||||||||||||||
| Total expenses | 2,732 | 2,857 | |||||||||||||||||||||
| Pretax income | 923 | 493 | |||||||||||||||||||||
| Income tax provision | 162 | 56 | |||||||||||||||||||||
| Net income | $ | 761 | $ | 437 | |||||||||||||||||||
| Earnings per share | |||||||||||||||||||||||
| Basic | $ | 6.69 | $ | 3.65 | |||||||||||||||||||
| Diluted | $ | 6.55 | $ | 3.58 |
See Notes to Consolidated Financial Statements.
AMERIPRISE FINANCIAL, INC.
CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (UNAUDITED)
| Three Months Ended March 31, | |||||||||||||||||||||||
| 2022 | 2021 | ||||||||||||||||||||||
| (in millions) | |||||||||||||||||||||||
| Net income | $ | 761 | $ | 437 | |||||||||||||||||||
| Other comprehensive income (loss), net of tax: | |||||||||||||||||||||||
| Foreign currency translation adjustment | (46) | (1) | |||||||||||||||||||||
| Net unrealized gains (losses) on securities | (853) | (340) | |||||||||||||||||||||
| Net unrealized gains (losses) on derivatives | 1 | — | |||||||||||||||||||||
| Defined benefit plans | — | 29 | |||||||||||||||||||||
| Total other comprehensive income (loss), net of tax | (898) | (312) | |||||||||||||||||||||
| Total comprehensive income | $ | (137) | $ | 125 |
See Notes to Consolidated Financial Statements.
AMERIPRISE FINANCIAL, INC.
CONSOLIDATED BALANCE SHEETS (UNAUDITED)
| March 31, 2022 | December 31, 2021 | ||||||||||
| (in millions, except share amounts) | |||||||||||
| Assets | |||||||||||
| Cash and cash equivalents | $ | 6,623 | $ | 7,127 | |||||||
| Cash of consolidated investment entities | 119 | 121 | |||||||||
| Investments (allowance for credit losses: 2022, $18; 2021, $18) | 36,040 | 35,810 | |||||||||
| Investments of consolidated investment entities, at fair value | 2,177 | 2,184 | |||||||||
| Separate account assets | 89,669 | 97,491 | |||||||||
| Receivables (allowance for credit losses: 2022, $51; 2021, $55) | 16,193 | 16,205 | |||||||||
| Receivables of consolidated investment entities, at fair value | 22 | 17 | |||||||||
| Deferred acquisition costs | 2,928 | 2,782 | |||||||||
| Restricted and segregated cash, cash equivalents and investments | 2,668 | 2,795 | |||||||||
| Other assets | 11,084 | 11,444 | |||||||||
| Other assets of consolidated investment entities, at fair value | 2 | 3 | |||||||||
| Total assets | $ | 167,525 | $ | 175,979 | |||||||
| Liabilities and Equity | |||||||||||
| Liabilities: | |||||||||||
| Policyholder account balances, future policy benefits and claims | $ | 35,225 | $ | 35,750 | |||||||
| Separate account liabilities | 89,669 | 97,491 | |||||||||
| Customer deposits | 22,048 | 20,227 | |||||||||
| Short-term borrowings | 200 | 200 | |||||||||
| Long-term debt | 2,330 | 2,832 | |||||||||
| Debt of consolidated investment entities, at fair value | 2,156 | 2,164 | |||||||||
| Accounts payable and accrued expenses | 2,050 | 2,527 | |||||||||
| Other liabilities | 8,691 | 8,966 | |||||||||
| Other liabilities of consolidated investment entities, at fair value | 146 | 137 | |||||||||
| Total liabilities | 162,515 | 170,294 | |||||||||
| Equity: | |||||||||||
| Common shares ($.01 par value; shares authorized, 1,250,000,000; shares issued, 335,320,837 and 334,828,117, respectively) | 3 | 3 | |||||||||
| Additional paid-in capital | 9,348 | 9,220 | |||||||||
| Retained earnings | 18,153 | 17,525 | |||||||||
| Treasury shares, at cost (225,174,867 and 223,967,107 shares, respectively) | (21,599) | (21,066) | |||||||||
| Accumulated other comprehensive income (loss), net of tax | (895) | 3 | |||||||||
| Total equity | 5,010 | 5,685 | |||||||||
| Total liabilities and equity | $ | 167,525 | $ | 175,979 |
See Notes to Consolidated Financial Statements.
AMERIPRISE FINANCIAL, INC.
**CONSOLIDAT
Showing the first 8K of 266K characters. Open the full section
Item 2. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS
The following discussion and analysis of our consolidated financial condition and results of operations should be read in conjunction with the “Forward-Looking Statements” that follow and our Consolidated Financial Statements and Notes presented in Item 1. Our Management’s Discussion and Analysis should be read in conjunction with our Annual Report on Form 10-K for the year ended December 31, 2021, filed with the Securities and Exchange Commission (“SEC”) on February 25, 2022 (“2021 10-K”), as well as our current reports on Form 8-K and other publicly available information. References below to “Ameriprise Financial,” “Ameriprise,” the “Company,” “we,” “us,” and “our” refer to Ameriprise Financial, Inc. exclusively, to our entire family of companies, or to one or more of our subsidiaries.
Overview
Ameriprise Financial is a diversified financial services company with a more than 125-year history of providing financial solutions. We are a long-standing leader in financial planning and advice with $1.3 trillion in assets under management and administration as of March 31, 2022. We offer a broad range of products and services designed to achieve individual and institutional clients’ financial objectives.
The coronavirus disease 2019 (‘‘COVID-19’’) pandemic has presented ongoing significant economic and societal disruption and market unpredictability, which has affected our business and operating environment driven by what has been a low interest rate environment and volatility and changes in the equity markets and the potential associated implications to client behavior. COVID-19 continues its ongoing impact and has been occurring in multiple waves, so there are still no reliable estimates of how long the implications from the pandemic will last, the effects current and other new variants will ultimately have, how many people are likely to be affected by it, or its impact on the overall economy. There is still significant uncertainty around the extent to which the COVID-19 pandemic will continue to impact our business, results of operations, and financial condition, which depends on current and future developments, including the ultimate scope, duration and severity of the pandemic, success of worldwide vaccination efforts, multiple mutations of COVID-19 or similar diseases, the effectiveness of our office reopenings, the additional measures that may be taken by various governmental authorities in response to the outbreak, the actions of third parties in response to the pandemic, and the possible further impacts on the global economy. Given the ongoing impact of the pandemic, financial results may not be comparable to previous years and the results presented in this report may not necessarily be indicative of future operating results. For further information regarding the impact of the COVID-19 pandemic, and any potentially material effects, see Part 1 - Item 1A “Risk Factors” of our 2021 10-K.
The products and services we provide retail clients and, to a lesser extent, institutional clients, are the primary source of our revenues and net income. Revenues and net income are significantly affected by investment performance and the total value and composition of assets we manage and administer for our retail and institutional clients as well as the distribution fees we receive from other companies. These factors, in turn, are largely determined by overall investment market performance and the depth and breadth of our individual client relationships.
Financial markets and macroeconomic conditions have had and will continue to have a significant impact on our operating and performance results. In addition, the business, political and regulatory environments in which we operate are subject to elevated uncertainty and substantial, frequent change. Accordingly, we expect to continue focusing on our key strategic objectives and obtaining operational and strategic leverage from our core capabilities. The success of these and other strategies may be affected by the factors discussed in Item 1A, “Risk Factors” in our 2021 10-K and other factors as discussed herein.
Equity price, credit market and interest rate fluctuations can have a significant impact on our results of operations, primarily due to the effects they have on the asset management and other asset-based fees we earn, the value of deferred acquisition costs (“DAC”) and deferred sales inducement costs (“DSIC”) assets, the values of liabilities for guaranteed benefits associated with our variable annuities and the values of derivatives held to hedge these benefits and the “spread” income generated on our fixed deferred annuities, fixed insurance, the fixed portion of variable annuities and variable insurance contracts and deposit products.
Earnings, as well as adjusted operating earnings after tax, may be impacted by the ongoing low interest rate environment. Although interest rates could rise in the future, we continue to operate within a comparatively low interest rate environment. In addition to continuing spread compression in our interest sensitive product lines, a sustained low interest rate environment may result in increases to our reserves and changes in various rate assumptions we use to amortize DAC and DSIC, which may negatively impact our adjusted operating earnings after tax. For additional discussion on our interest rate risk, see Item 3. “Quantitative and Qualitative Disclosures About Market Risk” and the information set forth in this Item 2, “Management’s Discussion and Analysis of Financial Condition and Results of Operations - Market Risk.”
On June 2, 2021, we filed an application to convert Ameriprise Bank, FSB to a state-chartered industrial bank regulated by the Utah Department of Financial Institutions and the Federal Deposit Insurance Corporation. We also filed an application to transition the FSB’s personal trust services business to a new limited purpose national trust bank regulated by the Office of the Comptroller of the Currency. If the applications are approved, the proposed changes are not expected to impact our long-term strategy for the bank and
AMERIPRISE FINANCIAL, INC.
should enable us to continue our strong lineup of banking solutions, including deposits, credit cards, mortgages and securities-based lending to our wealth management clients without interruption.
We consolidate certain variable interest entities for which we provide asset management services. These entities are defined as consolidated investment entities (“CIEs”). While the consolidation of the CIEs impacts our balance sheet and income statement, our exposure to these entities is unchanged and there is no impact to the underlying business results. For further information on CIEs, see Note 4 to our Consolidated Financial Statements. The results of operations of the CIEs are reflected in the Corporate & Other segment. On a consolidated basis, the management fees we earn for the services we provide to the CIEs and the related general and administrative expenses are eliminated and the changes in the fair value of assets and liabilities related to the CIEs, primarily syndicated loans and debt, are reflected in net investment income. We include the fees from these entities in the management and financial advice fees line within our Asset Management segment.
While our consolidated financial statements are prepared in accordance with U.S. generally accepted accounting principles (“GAAP”), management believes that adjusted operating measures, which exclude net realized investment gains or losses, net of the related DSIC and DAC amortization, unearned revenue amortization and the reinsurance accrual; the market impact on non-traditional long-duration products (including variable and fixed deferred annuity contracts and universal life (“UL”) insurance contracts, net of hedges and the related DSIC and DAC amortization, unearned revenue amortization and the reinsurance accrual; mean reversion rela
Showing the first 8K of 106K characters. Open the full section
Item 3. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK
The information set forth in Part I, Item 2, “Management’s Discussion and Analysis of Financial Condition and Results of Operations — Market Risk” in this report is incorporated herein by reference. These disclosures should be read in conjunction with the “Quantitative and Qualitative Disclosures About Market Risk” discussion included as Part II, Item 7A of our 2021 10-K filed with the SEC on February 25, 2022.
Item 4. CONTROLS AND PROCEDURES
Disclosure Controls and Procedures
We maintain disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e) of the Securities Exchange Act of 1934, as amended (the “Exchange Act”)) designed to provide reasonable assurance that the information required to be reported in the Exchange Act filings is recorded, processed, summarized and reported within the time periods specified in and pursuant to SEC regulations, including controls and procedures designed to ensure that this information is accumulated and communicated to our management, including our Chief Executive Officer and Chief Financial Officer, as appropriate, to allow timely decisions regarding the required disclosure. It should be noted that, because of inherent limitations, our company’s disclosure controls and procedures, however well designed and operated, can provide only reasonable, and not absolute, assurance that the objectives of the disclosure controls and procedures are met.
Our management, under the supervision and with the participation of our Chief Executive Officer and Chief Financial Officer, evaluated the effectiveness of the disclosure controls and procedures as of the end of the period covered by this report. Based upon that evaluation, our company’s Chief Executive Officer and Chief Financial Officer have concluded that our disclosure controls and procedures were effective at a reasonable level of assurance as of March 31, 2022.
AMERIPRISE FINANCIAL, INC.
Changes in Internal Control over Financial Reporting
There have not been any changes to our internal control over financial reporting (as such term is defined in Rules 13a-15(f) and 15d-15(f) under the Exchange Act) during the fiscal quarter to which this report relates that have materially affected, or are reasonably likely to materially affect, our company’s internal control over financial reporting.
PART II. OTHER INFORMATION
ITEM 1. LEGAL PROCEEDINGS
The information set forth in Note 16 to the Consolidated Financial Statements in Part I, Item 1 is incorporated herein by reference.
Item 1A. RISK FACTORS
There have been no material changes in the risk factors provided in Part I, Item 1A of our 2021 10-K.
ITEM 2. UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS
The following table presents the information with respect to purchases made by or on behalf of Ameriprise Financial, Inc. or any “affiliated purchaser” (as defined in Rule 10b-18(a)(3) under the Securities Exchange Act of 1934), of our common stock during the first quarter of 2022:
| Period | (a) | (b) | (c) | (d) | ||||||||||||||||||||||
| Total Number of Shares Purchased | Average Price Paid Per Share | Total Number of Shares Purchased as part of Publicly Announced Plans or Programs (1) | Approximate Dollar Value of Shares that May Yet Be Purchased Under the Plans or Programs (1) | |||||||||||||||||||||||
| January 1 to January 31, 2022 | ||||||||||||||||||||||||||
| Share repurchase program (1) | 334,220 | $ | 311.16 | 334,220 | $ | 3,328,441,337 | ||||||||||||||||||||
| Employee transactions (2) | 110,082 | $ | 304.64 | N/A | N/A | |||||||||||||||||||||
| February 1 to February 28, 2022 | ||||||||||||||||||||||||||
| Share repurchase program (1) | 475,911 | $ | 304.67 | 475,911 | $ | 3,183,446,834 | ||||||||||||||||||||
| Employee transactions (2) | 289,352 | $ | 311.08 | N/A | N/A | |||||||||||||||||||||
| March 1 to March 31, 2022 | ||||||||||||||||||||||||||
| Share repurchase program (1) | 623,973 | $ | 288.49 | 623,973 | $ | 3,003,438,420 | ||||||||||||||||||||
| Employee transactions (2) | 91,123 | $ | 297.15 | N/A | N/A | |||||||||||||||||||||
| Totals | ||||||||||||||||||||||||||
| Share repurchase program (1) | 1,434,104 | $ | 299.14 | 1,434,104 | ||||||||||||||||||||||
| Employee transactions (2) | 490,557 | $ | 307.05 | N/A | ||||||||||||||||||||||
| 1,924,661 | 1,434,104 |
N/A Not applicable.
(1) In August 2020, our Board of Directors authorized an expenditure of up to $2.5 billion for the repurchase of our common stock through September 30, 2022. In January 2022, our Board of Directors authorized an additional $3.0 billion for the repurchase of our common stock through March 31, 2024. The share repurchase program does not require the purchase of any minimum number of shares, and depending on market conditions and other factors, these purchases may be commenced or suspended at any time without prior notice. Acquisitions under the share repurchase program may be made in the open market, through privately negotiated transactions or block trades or other means.
(2) Includes restricted shares withheld pursuant to the terms of awards under the Company’s share-based compensation plans to offset tax withholding obligations that occur upon vesting and release of restricted shares. The value of the restricted shares withheld is the closing price of common stock of Ameriprise Financial, Inc. on the date the relevant transaction occurs. Also includes shares withheld pursuant to the net settlement of Non-Qualified Stock Option (“NQSO”) exercises to offset tax withholding obligations that occur upon exercise and to cover the strike price of the NQSO. The value of the shares withheld pursuant to the net settlement of NQSO exercises is the closing price of common stock of Ameriprise Financial, Inc. on the day prior to the date the relevant transaction occurs.
AMERIPRISE FINANCIAL, INC.
Item 6. EXHIBITS
Pursuant to the rules and regulations of the Securities and Exchange Commission, we have filed certain agreements as exhibits to this Quarterly Report on Form 10-Q. These agreements may contain representations and warranties by the parties. These representations and warranties have been made solely for the benefit of the other party or parties to such agreements and (i) may have been qualified by disclosures made to such other party or parties, (ii) were made only as of the date of such agreements or such other date(s) as may be specified in such agreements and are subject to more recent developments, which may not be fully reflected in our public disclosure, (iii) may reflect the allocation of risk among the parties to such agreements and (iv) may apply materiality standards different from what may be viewed as material to investors. Accordingly, these representations and warranties may not describe our actual state of affairs at the date hereof and should not be relied upon.
The following exhibits are filed as part of this Quarterly Report on Form 10-Q. The exhibit numbers followed by an asterisk (*) indicate exhibits electronically filed herewith. All other exhibit numbers indicate exhibits previously filed and are hereby incorporated herein by reference.
| Exhibit | Description | ||||
| 3.1 | Amended and Restated Certificate of Incorporation of Ameriprise Financial, Inc. (incorporated by reference to Exhibit 3.1 to the Current Report on Form 8-K, File No. 1-32525, filed on May 1, 2014). | ||||
| 3.2 | Amended and Restated Bylaws of Ameriprise Financial, Inc. (incorporated by reference to Exhibit 3.2 to the Annual Report on Form 10-K, File No. 1-32525, filed on February 24, 2021). | ||||
| 4.1 | Form of Specimen Common Stock Certificate (incorporated by reference to Exhibit 4.1 to Amendment No. 3 to Form 10 Registration Statement, File No. 1-32525, filed on August 19, 2005). Other instruments defining the rights of holders of long-term debt securities of the registrant are omitted pursuant to Section (b)(4)(iii)(A) of Item 601 of Regulation S-K. The registrant agrees to furnish copies of these instruments to the SEC upon request. | ||||
| 10.1†* | Ameriprise Financial Long-Term Incentive Award Program Guide | ||||
| 31.1* | Certification of James M. Cracchiolo pursuant to Rule 13a-14(a) promulgated under the Securities Exchange Act of 1934, as amended. | ||||
| 31.2* | Certification of Walter S. Berman pursuant to Rule 13a-14(a) promulgated under the Securities Exchange Act of 1934, as amended. | ||||
| 32* | Certification of James M. Cracchiolo and Walter S. Berman pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002. | ||||
| 101 | The following materials from Ameriprise Financial, Inc.’s Quarterly Report on Form 10-Q for the period ended March 31, 2022 are formatted in iXBRL (Inline eXtensible Business Reporting Language): (i) Consolidated Statements of Operations for the three months ended March 31, 2022 and 2021; (ii) Consolidated Statements of Comprehensive Income for the three months ended March 31, 2022 and 2021; (iii) Consolidated Balance Sheets at March 31, 2022 and December 31, 2021; (iv) Consolidated Statements of Equity for the three months ended March 31, 2022 and 2021; (v) Consolidated Statements of Cash Flows for the three months ended March 31, 2022 and 2021; and (vi) Notes to the Consolidated Financial Statements. | ||||
| 104 | The cover page from Ameriprise Financial, Inc.’s Quarterly Report on Form 10-Q for the period ended March 31, 2022 is formatted in iXBRL and contained in Exhibit 101. | ||||
| ** Filed electronically herewithin.* | |||||
| † Management contract or compensation plan or arrangement |
AMERIPRISE FINANCIAL, INC.
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
| AMERIPRISE FINANCIAL, INC. | |||||||||||
| (Registrant) |
| Date: | May 2, 2022 | By: | /s/ Walter S. Berman | ||||||||
| Walter S. Berman | |||||||||||
| Executive Vice President and Chief Financial Officer | |||||||||||
| (Principal Financial Officer) |
| Date: | May 2, 2022 | By: | /s/ John R. Hutt | ||||||||
| John R. Hutt | |||||||||||
| Executive Vice President / LFO – Finance | |||||||||||
| (Principal Accounting Officer) |